Tapani Luukkainen

Tapani Luukkainen's AcademicInfluence.com Rankings

Tapani Luukkainen

Philosophy

#9654

World Rank

#13244

Historical Rank

Logic

#6622

World Rank

#8155

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Tapani Luukkainen's Degrees

PhD Medical Sciences University of Helsinki
Doctorate Medicine University of Helsinki

Why Is Tapani Luukkainen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tapani Luukkainen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endometrial Morphology During Long‐Term Use of Levonorgestrel‐Releasing Intrauterine Devices (1986) (244)
TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD (1982) (198)
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. (1983) (180)
Gas-chromatographic behavior of trimethylsilyl ethers of steroids (1961) (164)
Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years' Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine Devices (1991) (153)
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. (1995) (137)
Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. (1984) (127)
Pharmacokinetics and metabolism of RU 486. (1987) (125)
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. (1987) (121)
Five years' experience with levonorgestrel-releasing IUDs. (1986) (120)
Plasma concentrations and receptor binding of RU 486 and its metabolites in humans. (1987) (111)
Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. (1990) (99)
Endometrial morphology of women using a d-norgestrel-releasing intrauterine device. (1978) (99)
Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. (2003) (98)
Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. (1988) (96)
Oestrogen-induced progesterone receptor in human uterus. (1975) (95)
GOSSYPOL, A POWERFUL INHIBITOR OF HUMAN SPERMATOZOAL METABOLISM (1980) (91)
Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. (1980) (90)
Distribution and percentages of non-protein bound contraceptive steroids in human serum. (1982) (80)
Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. (2003) (80)
Sustained intrauterine release of levonorgestrel over five years. (1986) (79)
Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. (1980) (77)
INTRAUTERINE CONTRACEPTION WITH LEVONORGESTREL: A COMPARATIVE RANDOMISED CLINICAL PERFORMANCE STUDY (1981) (76)
RETURN OF OVARIAN FUNCTION AFTER ABORTION (1978) (75)
Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. (1983) (72)
Progestin-releasing intrauterine systems. (2001) (71)
Hepatic Impairment During the Intake of Contraceptive Pills: Clinical Trial with Postmenopausal Women (1964) (71)
Metabolism and serum binding of RU 486 in women after various single doses. (1987) (70)
Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent. (1982) (65)
The levonorgestrel intrauterine system: therapeutic aspects (2000) (61)
Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices. (1980) (59)
The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation. (1995) (58)
The cytoplasmic progesterone receptor of human endometrium during the menstrual cycle. (1974) (57)
Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device. (1982) (54)
Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200. (1983) (52)
Liver-function Tests during Intake of Contraceptive Tablets in Premenopausal Women (1965) (50)
A D-norgestrel-releasing IUD. (1976) (48)
In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium. (1971) (44)
Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device. (1980) (41)
The use-effectiveness of the Copper-T-200 in a simulated field trial (1974) (41)
Urinary excretion of estriol and 15α-hydroxyestriol in complicated pregnancies☆ (1971) (39)
Immediate postabortion insertion of the copper-T (TCu-200) with eighteen months follow-up. (1974) (38)
Randomized comparison of clinical performance of two copper-releasing IUDs, Nova-T and Copper-T-200, in Denmark, Finland and Sweden. (1979) (37)
Progesterone-binding protein in human myometrium. Influence of metal ions on binding. (1974) (35)
The role of mitochondria in uterine contractions (1975) (35)
Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. (1982) (35)
Therapeutic use of the LNG IUS, and counseling. (2001) (34)
Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. (1990) (34)
Biochemical and clinical aspects of the enterohepatic circulation of oestrogens. (1967) (33)
Identification and determination of oestrogens in various biological materials in pregnancy. (1970) (33)
Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device. (2005) (33)
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device. (1982) (32)
Gas-liquid chromatographic and mass spectrometric studies on sterols in vernix caseosa, amniotic fluid and meconium. (1968) (32)
Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles. (1997) (32)
The Effect Of Oral Intake Of Ethyl Alcohol On The Activity Of The Pregnant Human Uterus (1967) (31)
Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel. (1975) (31)
Health and family planning services in the Chinese People's Republic. (1972) (31)
Isolation and identification of 11-dehydro-estradiol-17α, a new type of urinary steroid, in the urine of pregnant women (1965) (31)
Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435. (1982) (30)
Milligram-scale preparative gas chromatography of steroids and alkaloids (1962) (30)
Return of fertility after the removal of Nova T or copper T 200. (1982) (30)
The Oxidation of Glycosides. X. Reduction of Some Methyl D-Oxo-glucopyranosides. (1958) (28)
Vaginal contraception with gossypol: a clinical study. (1983) (28)
Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device. (1989) (27)
Return of ovulation after abortion and after discontinuation of oral contraceptives. (1980) (27)
Identification and determination of neutral steroid sulphates in human foetal adrenal and liver tissue. (1970) (27)
Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China. (1990) (27)
Nulliparous women, IUD and pelvic infection. (1979) (27)
Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacities. (1983) (26)
Intrauterine contraception with Nova-T and copper-T-200 during three years. (1981) (26)
Treatment of menorrhagia with an LNG-IUS. (2007) (26)
CHAPTER 7 – O-Methyloximes as Carbonyl Derivatives in Gas Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance† (1968) (26)
Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device. (1982) (25)
Discriminatory effect of anti-Pr-beta-hCG-TT antibodies on the neutralization of the biological activity of placental and pituitary gonadotropins. (1978) (25)
Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women. (1968) (25)
The Levonorgestrel-Releasing IUD (1988) (24)
The effect of progestin R 2323 released from vaginal rings on ovarian function. (1975) (23)
Two-year rates for Nova T and Copper T in a comparative study. (1980) (22)
Combined and national experience of postmenstrual IUD insertions of Nova-T and Copper-T in a randomized study. (1979) (22)
GAS-CHROMATOGRAPHIC STUDIES ON OESTROGENS IN THE BILE OF PREGNANT WOMEN. (1965) (22)
A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal. (1996) (21)
Neutral steroid sulfates in human ovarlian vein blood. (1970) (20)
Intracervical release of levonorgestrel for contraception. (1981) (19)
Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception. (1993) (19)
Hydrolysis of phospholipid monolayers by human spermatozoa. Inhibition by male contraceptive gossypol. (1985) (19)
Induction of premature labor in the rabbit after pretreatment with phospholipids. (1963) (18)
Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules. (1985) (18)
Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion. (1981) (18)
ST-1435: development of an implant. (1984) (17)
Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device. (1984) (17)
Neutral steroid sulphates in amniotic fluid. (1970) (16)
Immediate postabortal insertion of a levonorgestrel-releasing IUD. (1982) (15)
Factors Affecting the Clinical Performance of Nova T and Copper T 200 (1984) (15)
Progesterone-binding properties of microsomes from pregnant rat uterus. (1975) (13)
GAS CHROMATOGRAPHY OF METHYLATED ESTROGENS AND APPLICATION OF THE METHOD TO THE ANALYSIS OF HUMAN LATE PREGNANCY BILE. (1963) (13)
Issues to debate on the Women's Health Initiative: failure of estrogen plus progestin therapy for prevention of breast cancer risk. (2003) (13)
Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD. (1978) (13)
Contraception after thirty‐five (1992) (13)
Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules. (1984) (13)
Use-effectiveness of the copper-T300 during the first year. (1974) (12)
A radioimmunoassay of oestrone in plasma. Plasma levels of oestrone and oestradiol in oophorectomized Rhesus monkeys during treatment with subcutaneous implants containing oestrone. (1978) (12)
Pituitary and gonadal function during the use of norgestrelestradiol vaginal rings. (1978) (12)
Hysterographic studies with the copper T (TCu 200) in situ (1972) (12)
The Effect of œstrogen Treatment on Myometrial Activity in Late Pregnancy (1965) (11)
Long-term clinical experience with levonorgestrel-releasing IUD. (1985) (11)
Levonorgestrel-releasing intrauterine device. (1990) (11)
Immediate postabortal contraception with a microdose combined preparation: suppression of pituitary and ovarian function and elimination of HCG. (1978) (11)
Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435. (1981) (11)
Intrauterine release of levonorgestrel. (1983) (11)
The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle. (1974) (11)
Spermatogenesis in Men Treated with Subcutaneous Application of Levonorgestrel and Estrone Rods (1981) (11)
ISOLATION AND IDENTIFICATION OF 17α-OESTRADIOL IN THE BILE OF A PREGNANT COW (1965) (10)
Intravaginal administration of RU 486 in humans and rats: inadequate absorption in humans. (1987) (10)
Screening, Management, and Outcome of Pregnancy in Diabetic Mothers (1980) (10)
Long-term contraception with norethindrone subcutaneous capsules. (1976) (9)
The use of a contraceptive vaginal ring governed by the pattern of individual uterine bleeding. (1979) (9)
STUDIES OF HUMAN STEROIDAL HORMONES BY GAS CHROMATOGRAPHIC TECHNIQUES. (1963) (9)
INDUCTION OF LABOUR WITH INTRAVENOUS FAT EMULSION AT TERM (1964) (9)
Studies on conjugated mono- and dihydroxy metabolites of progesterone in plasma, bile and urine in a human subject. (1970) (9)
Important factors in the use-effectiveness of the copper-T-200 IUD. (1975) (9)
Sustained intrauterine release of d-norgestrel. (1978) (9)
Early puerperal insertions of copper-T-200. (1975) (9)
Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception. (1979) (8)
Intracervical release of ST-1435 for contraception. (1984) (8)
Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginally. (1984) (8)
Simultaneous determination of urinary estrogens, individual 11-deoxy-17-ketosteroids, total 17-ketosteroids, total 17-ketogenic steroids, pregnanediol and plasma cortisol during the menstrual cycle and in early pregnancy. (1967) (7)
An oestrone-releasing vaginal ring in the treatment of climacteric women. (1980) (7)
Gas Phase Chromatographic Methods for Estrogens in Biological Fluids (1968) (7)
Acceptability of an experimental intracervical device: results of a study controlling for selection bias. (1989) (7)
Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol. (1979) (7)
Pharmacokinetic Studies on Low Dose Estradiol 17β Administered Orally to Postmenopausal Women (1980) (6)
DISULPHATES OF NEUTRAL STEROIDS IN THE AMNIOTIC FLUID FROM ANENCEPHALIC PREGNANCIES (1971) (6)
IMPORTANCE OF THE TYPE OF THE PROGESTOGEN IN ORAL CONTRACEPTIVES (1966) (6)
Effect of Progesterone on Pregnancy: Effect of a Phospholipid Factor on the Activity of Progesterone (1961) (6)
Multiclinic copper T studies in Finland. (1974) (5)
The Sulphur-Sulphur Bonds in Thiothiophthene Derivatives. (1968) (5)
A Possible regulatory role of mitochondrial calcium uptake in uterine contractions. (1974) (5)
In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic and carcinomatous endometrium☆ (1972) (5)
The effect of testosterone, progesterone and estrogen on the acetylating activity in rat liver and kidney preparations. (1961) (5)
Contraception with a levonorgestrel-releasing IUD: effect on lactation and child development. (1984) (5)
Four years of a comparative study with Nova T and Copper T 200 IUDS. (1982) (5)
Performance of copper and steroid-releasing IUDs. (1978) (4)
Testosterone binding of maternal plasma in twin pregnancy (1970) (4)
Gas chromatographic and mass spectrometric identification of neutral and phenolic steroids in amniotic fluid. (1969) (4)
Contraception with a norethisterone-releasing IUD. Plasma levels of norethisterone and its influence on the ovarian function. (1978) (4)
Studies in the acetylation of p-aminobenzoic acid and its regulation by the sex glands in the rat organism. (1958) (4)
Determination of Urinary Estrogens by Gas Chromatography (1965) (4)
OESTROGEN-INDUCED PROGESTERONE RECEPTOR IN HUMAN UTERUS (1976) (4)
[Nova-T and Copper-T 200 in a five year's clinical comparison]. (1983) (4)
Effect of benzoic acid on the metabolic conjugations of p-aminobenzoic acid in the rat. (1958) (4)
Effect of growth hormone and of pregnancy on the hydroxyproline concentration of the blood of rats. (1958) (4)
Gas chromatographic and mass spectrometric studies in the influence of metabolites of bis(p-acetoxyphenyl)cyclohexylidenemethane on the estimation of estrogens in urine. (1967) (4)
Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200 (1984) (3)
The 1992 Indonesia Norplant Use-Dynamics Study: final report. Population Council Contract No. CI91. 99A. December 1 1991-April 30 1993 (1993) (3)
Acetylation of p-aminobenzoic acid in various animal tissues in vitro. (1959) (3)
Mass spectrometric studies in the specificity of estriol determination in urine by gas-liquid chromatography. (1967) (3)
Effect of benzoate and salicylate on the acetylation of p-aminobenzoic acid in ox kidney in vitro. (1959) (3)
Steroid methoximes II: Antifertility activity of norethisterone-3-methoxime in the rat. (1975) (3)
[Randomized comparison of clinical performance of two copper-releasing IUDs, NOVA-T and Copper-T-200, in Denmark, Finland and Sweden with a special reference on pelvic infection]. (1979) (3)
Microangiographic observations on the uterine and maternal placental vasculature in early human pregnancy. (1974) (3)
GAS CHROMATOGRAPHIC IDENTIFICATION OF PREGNANEDIOL AND SOME OF ITS ISOMERS IN BILE OF PREGNANT WOMEN. (1964) (3)
Silastic implants releasing estrone in the treatment of climacteric complaints. (1980) (3)
Steroid methoximes I: Antifertility activity of methoxime derivatives of progesterone, estrone and 16-ketoestradiol in the rat. (1975) (3)
Urinary excretion of estriol and 15 alpha-hydroxyestriol in complicated pregnancies. (1971) (2)
Medicated intrauterine devices for contraception and their therapeutic effects (2006) (2)
Liver-function Tests during Intake of Contraceptive Tablets in Pre-menopausal Women (2007) (2)
Choice of contraceptives. (1978) (2)
Levonorgestrel plasma concentrations and hormone profiles after 1 year of treatment with a levonorgestrel-IUD. (1980) (2)
146. Progesterone-binding properties of microsomes from rat myometrium (1974) (2)
Isolation and identification of II-dehydro-estradiol-17-alpha, a new type of urinary steroid, in the urine of pregnant women. (1965) (1)
Levonorgestrel-releasing intrauterine devices (1986) (1)
New methods for the regulation of female fertility. (1981) (1)
EFFECT OF HUMAN PITUITARY FOLLICLE-STIMULATING (HP-FSH) HORMONE ON URINARY EXCRETION OF 8 DIFFERENT OESTROGENS, 11-DEOXY-17-KETOSTEROIDS AND PREGNANEDIOL IN A PATIENT WITH POLYCYSTIC OVARIES (1967) (1)
[Contraceptive coils and their problems]. (1987) (1)
Testing the clinical performance of Nova-T versus Copper-T 200. [Abstract] (1980) (1)
Treatment of symphyseolysis with relaxin. (1963) (1)
Correlation of Syntocinon Sensitivity and Uterine Response at Term with the Course of Induced Labour (1964) (1)
The effect of cortisone on the purine content in the rat spleen. (1954) (1)
[Methods for the gas chromatography and mass spectrometry of "new oestrogens" (author's transl)]. (1971) (1)
The levonorgestrel releasing IUD (LNG IUD) (1992) (1)
Studies in the glucose tolerance test in STH-treated rats during pregnancy. (1958) (0)
Nova-T/Copper-T comparative study. (1978) (0)
BIODEGRADABLE POLYLACTATE AS A STEROID-RELEASING POLYMER: INTRAUTERINE ADMINISTRATION OF d-NORGESTREL (1975) (0)
[Contraception in the next millenium]. (1997) (0)
262. Postabortal contraception with norethisterone-acetate injections (1982) (0)
Nova-T: long-term effectiveness and clinical performance [abstract] (1983) (0)
[Health benefits of contraception]. (1992) (0)
CONTRACEPTION WITH A NORETHISTERONE-RELEASING IUD. PLASMA LEVELS OF NORETHISTERONE AND ITS INFLUENCE ON THE OVARIAN FUNCTION (1978) (0)
NORETHISTERONE-3-METHOXIME IN THE RAT (1975) (0)
Effect of phospholipids on the subcellular distribution of progesterone in pregnant rat myometrium and on protein binding of progesterone. (1972) (0)
Effect of somatotropin (STH) on the maternal organism during pregnancy. (1957) (0)
Intrauterine device with and without hormones (1984) (0)
The effect on an infusion of phospholipid on the human myometrium early in pregnancy. (1963) (0)
Urinary metabolites of p-aminobenzoic acid in man: effect of benzoate. (1959) (0)
[Comparative results on two years use of Nova T and Copper T]. (1980) (0)
Progestin-releasing intrauterine devices. (1997) (0)
Testing the Clinical Performance of an IUD (1980) (0)
[Intrauterine devices]. (1973) (0)
261. Intracervical contraceptive device releasing a new progestin, ST-1435 (1982) (0)
METOPIRONE AND PLASMA SOLVOLYZABLE STEROIDS (1967) (0)
Original research article Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up (2003) (0)
The development of levonorgestrel IUD. (1982) (0)
The effect of acetylsalicylic acid on the total purine content of the rat spleen. (1954) (0)
TESTOSTERONE BINDING AND ESTROGEN EXCRETION IN NORMAL AND TWIN PREGNANCIES AND IN A PREGNANT WOMAN WITH ADDISON DISEASE (1969) (0)
Oestradiol and depression [letter] (1993) (0)
Coenzyme A in livers of rats treated with growth hormone (STH). (1957) (0)
Effect of Angiotensin on Urinary Electrolytes Before and After Lipid Infusion in Early Human Pregnancy (1964) (0)
[Is there a reason for changing the hormone treatment?]. (1990) (0)
RECENT ADVANCES IN INTRAUTERINE CONTRACEPTION (1975) (0)
Formation of p-aminobenzoate conjugates in rat liver and kidney in vitro. Effect of benzoate and salicylate. (1963) (0)
Choice of contraceptives. (1978) (0)
Development of intracervical steroid-releasing system. (1984) (0)
[Choice of contraceptives]. (1978) (0)
Concerns with the report from Wildemeersch et al. (2006) (0)
Experiences with Intrauterine Blood Transfusions (1969) (0)
Effect of the rupture of the membranes on the uterine activity. (1962) (0)
Serum non-protein bound percentages and distribution of contraceptive steroids (1981) (0)
[Hormonal coils]. (1987) (0)
Combination of progestogen therapy with the conventional treatment of endometrial carcinoma. (1970) (0)
LHRH analogs and androgens for male fertility control [abstract] (1984) (0)
The distribution of injected C14-progesterone in the subcellular fractions of rat myometrium before and after parturition. (1967) (0)
[One year experience of levonorgestrel-releasing intrauterine device]. (1991) (0)
Vaginal contraception with gossypol: A clinical study (1984) (0)
GAS CHROMATOGRAPHIC METHODS FOR URINARY OESTROGENS (1965) (0)
[PROGESTERONE, PROGESTOGENS AND GESTAGENS]. (1963) (0)
[Are ectopic pregnancies are reducing?]. (1997) (0)
ISOLATION AND IDENTIFICATION OF 17-ALPHA-OESTRADIOL IN THE BILE OF A PREGNANT COW. (1965) (0)
Discussion: long-acting contraceptive delivery systems: additional clinical studies. (1984) (0)
[Intrauterine fetal diagnostics]. (1969) (0)

This paper list is powered by the following services:

Tapani Luukkainen's Academic­Influence.com Rankings

Tapani Luukkainen's Degrees

Why Is Tapani Luukkainen Influential?

Tapani Luukkainen's Published Works

Published Works

Tapani Luukkainen's AcademicInfluence.com Rankings